Latest news
FARALLON CAPITAL MANAGEMENT LLC Adds to Crinetics Pharmaceutical - GuruFocusGuruFocus · Sat, 08 Aug 2026 07:23:37 GMT$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger—CRNX, PSBQ, D, and NEE - mykxlg.commykxlg.com · Fri, 07 Aug 2026 23:00:00 GMTCrinetics Pharmaceuticals (NASDAQ: CRNX) sees 1.4% stake reported by FMR LLC - Stock TitanStock Titan · Fri, 07 Aug 2026 15:05:25 GMTCrinetics Pharmaceuticals (CRNX) Stock Looks Rich On Book Value But Reasonable On Deal Value - SahmSahm · Thu, 06 Aug 2026 07:00:00 GMTCrinetics Pharmaceuticals (CRNX) Stock Lags As Revenue Builds And Losses Deepen - SahmSahm · Wed, 05 Aug 2026 07:00:00 GMTCrinetics Pharmaceuticals (CRNX) On Vertex Deal Optimism And Results Looks Nearly Fully Valued - finance.yahoo.comfinance.yahoo.com · Tue, 04 Aug 2026 21:11:40 GMTCrinetics Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Tue, 04 Aug 2026 21:01:40 GMTCrinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Revenue Growth Surges by 2,873% Amidst Strong Biotech Potential - DirectorsTalk InterviewsDirectorsTalk Interviews · Tue, 04 Aug 2026 09:11:47 GMT